Skip to main content
SpringerLink
Log in

Cytomegalovirus and the Aging Population

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Human cytomegalovirus (HCMV) has the largest genome of any virus known to infect man. The virus has evolved many strategies to manipulate the host immune systems and so can remain latent and evade important immune responses. The human host mounts a substantial immune response against the virus, with up to 1% of the virus-specific CD8+ T cells being directed against specific epitopes.

Acquisition of HCMV occurs progressively from an early age, and in developed countries the overall seroprevalence is approximately 60%. In contrast, specific communities such as gay men, lower socioeconomic groups and people residing in developing countries have seroprevalence rates that can exceed 90%.

It is a widely held belief that successful control of viral infections decreases with increasing age because of a reduction in the capacity of the immune system. Studies in aging populations have shown a specific expansion of the CD8+, CD28− and CD57+ subset of cells in patients who are HCMV-seropositive. Prior infection with HCMV has also been associated with a significantly increased number of CD4+ and CD8+ lymphocytes, as well as cells expressing CD56 and HLA-DR. Thus, HCMV infection can cause substantial perturbations in T cell subsets and these effects persist in the aging population.

In the context of solid organ transplantation, older age of both recipients and donors may serve to increase the frequency of donor-positive recipient-positive (D+R+) transplants, which have only a moderate risk of HCMV disease. In the context of HIV infection, age has been a dominant risk factor for progression to AIDS and death. At present, it does not appear that this can be explained by lack of immune control of HCMV in the aging population, although studies have identified prior HCMV infection as a risk factor for AIDS and death independent of age.

We await further investigations to determine whether the immune control of HCMV in the elderly patient is as effective as in the younger adult, and whether this is linked to pathological consequences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Griffiths PD, Emery VC. Cytomegalovirus. In: Richman D, Whitley R, Hay den F, editors. Clinical virology. New York (NY): Churchill Livingston Inc, 1997: 445–470

    Google Scholar 

  2. Stagno S. Cytomegalovirus. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadelphia: W.B. Saunders, 1990: 240–281

    Google Scholar 

  3. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection [see comments]. Nature 1995; 373(6510): 123–6

    Article  PubMed  CAS  Google Scholar 

  4. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection [see comments]. Nature 1995; 373: 117–22

    Article  PubMed  CAS  Google Scholar 

  5. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282(5386): 103–7

    Article  PubMed  CAS  Google Scholar 

  6. Nowak MA, Bonhoeffer S, Hill AM, et al. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996; 93(9): 4398–402

    Article  PubMed  CAS  Google Scholar 

  7. Emery VC, Cope AV, Bowen EF, et al. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 1999; 190(2): 177–82

    Article  PubMed  CAS  Google Scholar 

  8. Emery VC, Sabin CA, Cope AV, et al. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355(9220): 2032–6

    Article  PubMed  CAS  Google Scholar 

  9. Emery VC. Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host. In: Scholz M, Rabenau HF, Doerr HW, et al., editors. CMV-related immunopathology. Frankfurt: Karger, 1998: 288–301

    Google Scholar 

  10. Mendez J, Espy M, Smith TF, et al. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 1998; 65(11): 1477–81

    Article  PubMed  CAS  Google Scholar 

  11. Britt WB, Mach M. Human cytomegalovirus glycoproteins. Intervirology 1996; 39(5–6): 401–12

    PubMed  CAS  Google Scholar 

  12. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70(11): 7569–79

    PubMed  CAS  Google Scholar 

  13. Kern F, Surel IP, Faulhaber N, et al. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol 1999; 73(10): 8179–84

    PubMed  CAS  Google Scholar 

  14. Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995; 171(5): 1115–21

    Article  PubMed  CAS  Google Scholar 

  15. Hassan-Walker AF, Vargas Cuero AL, Mattes FM, et al. CD8 cytotoxic lymphocyte responses against cytomegalovirus following liver transplantation: correlation with time from transplant and receipt of tacrolimus. J Infect Dis 2001; 183:835–43

    Article  PubMed  CAS  Google Scholar 

  16. Singhai S, Shaw JC, Ainsworth J, et al. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients [see comments]. Transplantation 2000; 69(11): 2251–9

    Article  Google Scholar 

  17. Engstrand M, Tournay C, Peyrat MA, et al. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 2000; 69(11): 2243–50

    Article  PubMed  CAS  Google Scholar 

  18. Reynolds DW, Stagno S, Stubbs KG, et al. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency. N Engl J Med 1974; 290(6): 291–6

    Article  PubMed  CAS  Google Scholar 

  19. Deayton J, Mocroft A, Wilson P, et al. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. AIDS 1999; 13(10): 1203–6

    Article  PubMed  CAS  Google Scholar 

  20. Deayton JR, Wilson P, Sabin CA, et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy [in process citation]. AIDS 2000; 14(9): 1163–70

    Article  PubMed  CAS  Google Scholar 

  21. Autran B, Carcelaint G, Li TS, et al. Restoration of the immune system with anti-retroviral therapy. Immunol Lett 1999; 66(1–3): 207–11

    Article  PubMed  CAS  Google Scholar 

  22. Stagno S, Reynolds DW, Pass RF, et al. Breast milk and the risk of cytomegalovirus infection. N Engl J Med 1980; 302(19): 1073–6

    Article  PubMed  CAS  Google Scholar 

  23. Stagno S. Cytomegalovirus. In: Rimington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadephia: W.B. Saunders, 1990: 240–81

    Google Scholar 

  24. Griffiths PD, Baboonian C, Rutter D, et al. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol 1991; 98(2): 135–40

    Article  PubMed  CAS  Google Scholar 

  25. Griffiths PD, Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol 1984; 91: 307–15

    Article  PubMed  CAS  Google Scholar 

  26. Doria G, Frasca D. Genes, immunity, and senescence: looking for a link. Immunol Rev 1997; 160: 159–70

    Article  PubMed  CAS  Google Scholar 

  27. Schmader K. Herpes zoster in the elderly: issues related to geriatrics. Clin Infect Dis 1999; 28(4): 736–9

    Article  PubMed  CAS  Google Scholar 

  28. Merino J, Martinez-Gonzalez MA, Rubio M, et al. Progressive decrease of CD8high+ CD28+CD57 -cells with ageing. Clin Exp Immunol 1998; 112(1): 48–51

    Article  PubMed  CAS  Google Scholar 

  29. Looney RJ, Falsey A, Campbell D, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999; 90(2): 213–9

    Article  PubMed  CAS  Google Scholar 

  30. Schmader KE, Rahija R, Porter KR, et al. Aging and reactivation of latent murine cytomegalovirus. J Infect Dis 1992; 166(6): 1403–7

    Article  PubMed  CAS  Google Scholar 

  31. Transplant Patient Data Source (2000, February 16). Richmond (VA): United Network for Organ Sharing. Available from URL: http://www.unos.org/data.htm[Accessed 2001 Dec 14]

  32. Valantine HA, Gao S-Z, Menon SG, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: A post-hoc analysis of a randomised, placebo-controlled study. Circulation 1999; 100: 61–6

    Article  PubMed  CAS  Google Scholar 

  33. Evans PC, Soin A, Wreghitt TG, et al. An association between cytomegalovirus infection and chronic rejection after liver transplantation. Transplantation 2000; 69(1): 30–5

    Article  PubMed  CAS  Google Scholar 

  34. Lowance D, Neumayer H-H, Legendre C, et al. Valaciclovir reduces the incidence of cytomegalovirus disease and acute rejection in renal allograft recipients. N Engl J Med 1999; 340: 1462–70

    Article  PubMed  CAS  Google Scholar 

  35. Griffiths PD, Ait-Khaled M, Bearcroft C, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999; 59: 496–501

    Article  PubMed  CAS  Google Scholar 

  36. Phillips AN, Lee CA, Elford J, et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr 1991; 4: 970–5

    PubMed  CAS  Google Scholar 

  37. Spector SA, Hirata KK, Newman TR. Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome. J Infect Dis 1984; 150(6): 953–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Research in the author’s laboratory is supported by US National Institutes of Health, UK Medical Research Council and The Wellcome Trust. No conflicts of interest declared.

Author information

Authors and Affiliations

  1. Virology Department, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St, London, NW3 2PF, England

    Vincent C. Emery

Authors
  1. Vincent C. Emery
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincent C. Emery.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Emery, V.C. Cytomegalovirus and the Aging Population. Drugs Aging 18, 927–933 (2001). https://doi.org/10.2165/00002512-200118120-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200118120-00004

Keywords

Search

Navigation